Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Shanchol Cholera Vaccine in Ethiopia
NCT01524640Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Dec 2012
- Primary completion
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of cholera vaccine (inactivated, oral) in cholera, sponsored by International Vaccine Institute. Started Dec 2012; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT01524640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524640.